Perceptive

Executive Summary

Perceptive is a UK-based specialized services provider for the global biopharmaceutical industry, offering preclinical and clinical trial imaging as well as Randomization and Trial Supply Management (RTSM). Founded in 2016, the company leverages over 50 years of combined expertise to deliver high-quality data that accelerates drug development from discovery through late-phase clinical trials. By focusing on imaging and RTSM, Perceptive enables biopharma clients to reduce trial timelines and improve data quality, ultimately helping bring essential treatments to patients faster. As a private company in the AI/Machine Learning, Drug Delivery, and Digital Health categories, Perceptive is positioned to benefit from the increasing complexity of clinical trials and the growing reliance on specialized service providers. While its financials and valuation are undisclosed, its established presence in London and focus on high-demand areas suggest steady growth. The company's success hinges on its ability to secure repeat business and expand its client base, particularly as biopharma companies seek efficiencies in drug development.

Upcoming Catalysts (preview)

• TBDMajor Contract Win with Top Pharma70% success
• TBDLaunch of AI-Enhanced Imaging Analytics60% success
• TBDStrategic Acquisition or Partnership40% success